Novartis announced yesterday that it has launched an app specifically designed for eye patients to participate in ophthalmic clinical trials. Built with ResearchKit, the FocalView app looks to improve ...

Qualcomm Life announced two major partnerships at CES15 this year: one with pharmaceutical company Novartis and the other with pharmacy chain Walgreens. Novartis selected Qualcomm Life as a partner ...

EAST HANOVER, N.J., Aug. 11, 2025 /PRNewswire/ -- Novartis today announced positive top-line results from its Phase III trials evaluating ianalumab (VAY736) in adults with active Sjögren's disease.

Clinical trial collaboration and supply agreement enables pivotal Phase 3 OPERA-02 clinical trial of palazestrant in combination with ribociclib in frontline ER+/HER2- metastatic breast cancer; trial ...

Novartis on Wednesday said that the US Food and Drug Administration (FDA) placed a partial hold on intrathecal clinical trials of its gene therapy Zolgensma (onasemnogene abeparvovec-xioi) for spinal ...

In May 2024, BioWorld covered 298 updates across phase I-III clinical trials, surpassing March (261), February (236) and January (252), though falling short of April’s high of 323. Additionally, at ...

(RTTNews) - Swiss drug major Novartis AG (NVS) announced Monday positive topline results from a pre-specified interim analysis of the Phase III PSMAddition trial for Pluvicto plus hormone therapy in ...

As part of Novartis’ new drug application for its recently approved multiple sclerosis drug Mayzent (siponimod), the US Food and Drug Administration (FDA) questioned the drugmaker’s data practices ...

Her career has taken her from treating patients to developing new medicines for biopharma, and now Nancy L. Lewis, MD, MBS, ...

ETHealthworld.com brings latest novartis india news, views and updates from all top sources for the Indian Health industry.